Docking analysis of a series of cytochrome P-450(14αDM) inhibiting azole antifungals

Drug Design and Discovery

Volumn 15, Issue 3, 1998, Pages 181-190

  Talele, Tanaji T ^a   Hariprasad, V ^a   Kulkarni, Vithal M ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

Conformational analysis; Cytochrome P 450; Docking

Indexed keywords

ANTIFUNGAL AGENT; CYTOCHROME P450; PYRROLE;

ARTICLE; DRUG DESIGN; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR MODEL;

ANTIFUNGAL AGENTS; AZOLES; CHEMISTRY, PHYSICAL; CYTOCHROME P-450 ENZYME SYSTEM; ENERGY TRANSFER; ENZYME INHIBITORS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OXIDOREDUCTASES; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

EID: 0031839806     PISSN: 10559612     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Tafi, A., Anastassopoulou, J., Theophanides, T., Botta, M., Corelli, F., Massa, S., Artico, M., Costi, R , Di Santo, R. and Ragno, R. (1996). Molecular Modeling of Azole Antifungal Agents Active Against Candida albicans. I A Comparative Molecular Field Analysis Study J. Med. Chem., 39, 1227-1235.
2. Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V. and Adams, D. J. (1990). Interaction of Azole Antifungal Antibiotics with Cytochrome P-450 Dependent 14 α-Sterol Demethylase Purified from Candida albicans. Biochem. J . 266, 475-480.
3. CAM. J. Biol. Chem., 257, 10427-10429.
4. CAM . Biochemistry, 32, 4571 -4578.
5. Yeagle, P. L., Martin, R. B., Lala, A. K., Lin, H. K. and Block, K (1977). Differential Effects of Cholesterol and Lanosterol on Artificial Membranes Proc. Natl. Acad. Sci. U.S.A., 74, 4924-4926.
6. 14αDM Purified from Saccharomyces cerevisiae Microsomes Biochem. Pharmacol., 36, 229-235.
7. Sammes, P. G. (1982). Topics In Antibiotic Chemistry, Sammes, P. G., Ed.; Ellis Horwood Limited, Chichester, 6, pp 22-97.
8. Veronese, M., Salvaterra, M. and Barzaghi, D. (1981). Fenticonazole. a New Imidazole Derivative with Antibacterial and Antifungal Activity. Arzneim.-Forsch., 31, 2133-2137.
9. Benfield. P. and Clissold, S. P. (1988). Sulconazole: A Review of its Antimicrobial Activity and Therapeutic Use in Superficial Dermatomycoses. Drugs, 35, 143-153.
10. a) Van Dyck, P. C. M., Ligtvoet, T. M. C. and Van Leemput, L. J. J. (1986). Water-dilutable wood-preserving liquids. Chem. Abstr., 104, P70538w.
11. b) Gutsche, K., Kohlmann, F. W and Scharwaechter, P. (1977). Imidazole derivatives. Chem. Abstr., 87, P102327a.
12. c) Rane, D. F , Desai, J. A. and Pike, R E. (1986). 2-Azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluorobenzo[b]thiophenes and compositions containing them. Chem. Abstr., 105, P152918e.
13. Drugs of the Future, (1988), 13, 624-626.
14. Fromtling, R. A. (1985). Drugs of the Future, 10, 983-984.
15. Drugs of the Future, (1981), 6, 444-445
16. Fromtling, R. A. (1985). Drugs of the Future, 10, 293-294.
17. James Reynolds, E. F. (1993). MARTINDALE The Extra Pharmacopoeia, Thirtieth Edition. James E F. Reynolds., Ed.; THE PHARMACEUTICAL PRESS, LONDON, pp 315-332.
18. cam. Biochemistry, 26, 8165-8174.
19. Wade, C R. (1990). Solvation of the active site of cytochrome P450-cam. J. Comput.-Atded Mol. Des., 4, 199-204.
20. Isbister, B. D., Hilaire, P. M. St. and Toone, E. J. (1995). Spatial Organization versus Total Surface Area as a Predictor of Protein Hydrophobicity. The Hydrophobicity of the Concanavalin A Binding Site. J. Am. Chem Soc., 117. 12877-12878.
21. Brooks, B R., Bruccoleri, R. E., Olafson, B. D., States, D. J , Swaminathan, S. and Karplus, M. (1983). CHARMM: A Program for Macromolecular Energy Minimization and Dynamics Calculations. J. Comput. Chem., 4, 187-217.
22. QUANTA (version 4.0) (1993) Molecular Simulations Inc. 9685 Scranton Road, San Diego, CA 92121-3752, USA.
23. cam. J. Mol. Biol., 195, 687-700.
24. Cam- J. Biol. Chem., 256, 6686-6691.
25. Poulos, T. L., Finzel, B C. and Howard, A J. (1986). Crystal Structure-Free Psendomonas putida Cytochrome P-450. Biochemistry, 25, 5314-5322.
26. Bernstein, F C., Koetzel, T. F., Williams, G. J. B., Meyer, Jr E F., Brice, M. D., Rodger, J. R., Kennard, O. T. and Tasumi, M. (1977). The Protein Data Bank: A Computer-based Archival file for Macromolecular Structures. J. Mol. Biol., 112, 535-542.
27. Hariprasad, V. and Kulkarni, V. M. (1996). A Molecular Dynamics Study of the Three-Dimensional Model of Human Synovial Fluid Phospholipase A2-Transition State Mimic Complexes. J. Mol. Recogn., 9, 95-102.
28. Bhalla, D. V. and Kulkarni, V M. (1993). High-temperature quenched molecular dynamics simulations of somatostatin and constrained analogues. Med. Chem. Res., 3, 163-170.
29. Levit, M and Lifson, S. (1969). Refinement of Protein Conformations using a Macro olecuiar Energy Minimization Procedure. J. Mol. Biol., 46, 269-279.
30. Wang, H. and Ben-Naim, A. (1996). A Possible Involvement of Solvent-Induced Interactions in Drug Design. J. Med. Chem., 39, 1531-1539.
31. Orozco, M., Laughton, C. A., Herzyk, P. and Neidle, S. (1990). Molecular Mechanics Modeling of Drug-DNA Structures: The Effect of Differing Dielectric Treatment on Helix Parameters and Comparison with a Fully Solvated Structure Model. J. Biomol. Struct. Dyn., 8, 359-373.